The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...
JPMorgan Chase reported fourth-quarter results Wednesday that came in above analysts' expectations as investment banking fees ...
JPMorgan Chase management disabled comments on an internal webpage where the policy was announced, according to the Wall ...
JPMorgan Chase reported fourth-quarter earnings before the opening bell Wednesday. Here's what the company reported compared ...
Betsy Graseck, an analyst from Morgan Stanley, maintained the Hold rating on JPMorgan Chase & Co. (JPM – Research Report). The associated ...
JPMorgan Chase (NYSE: JPM) Q4 2024 Earnings Call Jan 15, 2025, 8:30 a.m. ET Good morning, ladies and gentlemen. Welcome to ...
JPMorgan Chase significantly exceeded fourth-quarter expectations with strong earnings, despite challenges like credit costs ...
AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...
The radiopharmaceutical developer expanded its reach, acquiring R&D, isotope production, manufacturing, and distribution.